Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
nanatinostat (VRx-3996) - Viracta Therapeutics
https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-orphan-drug-designation-granted-for-the-treatment-of-t-cell-lymphoma-301083191.html
 
Jun 24, 2020
 
Prev Next